Clinical trial of comparison of efficacy of Halita mouthrine with chlorhexidine mouthrine in reducing oral malodor in patients with halitosis in 7-day consumption

INTERVENTION: 0.05% chlorhexidine mouth rinse in 140 ml volume for 7‐day use (14 doses) 10 ml for one dose. Halita(containing 0.05% chlorhexidine, 0.05% cetylpyridinium chloride, and zinc) mouth rinse in 140 ml volume for 7‐day use (14 doses) 10 ml for one dose. Intervention 1: 0.05% chlorhexidine mouth rinse in 140 ml volume for 7‐day use (14 doses) 10 ml for one dose. Intervention 2: Halita(containing 0.05% chlorhexidine, 0.05% cetylpyridinium chloride, and zinc) mouth rinse in 140 ml volume for 7‐day use (14 doses) 10 ml for one dose. Treatment ‐ Drugs CONDITION: Halitosis Oral halitosis. ; Halitosis PRIMARY OUTCOME: Oral halitosis. Timepoint: before intervention and after 7 days of intervention. Method of measurement: Organoleptic measurement. INCLUSION CRITERIA: INCLUSION CRITERIA: Organoleptic score (OLS) of over 2. Exclusion criteria: Alcohol and tobacco use; Systemic diseases; Medications that cause dry mouth; Consumption of antibiotics in the previous two weeks; Pocket depth greater than 6 mm; Eating spicy foods, onion, and garlic 48 hours prior to the examination; Use of orthodontic appliances (fixed or removable) and removable dental prosthesis; Allergy or any undesirable reactions to either of test mouthrinses. It should be noted that, during the study period, the participants did not receive dental procedures such as scaling, restoration, etc. and thus their oral health conditions were unchanged.